GlassScriptPhysician profile
Stephen B Saltz
NPI 1275599565
$3,042.66
in general payments reported to CMS, 2019-2025
29 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $253 · 2021: $600 · 2022: $571 · 2023: $375 · 2024: $291 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $685.99 | 2019-2023 | Mitraclip |
| Medtronic, INC. | $464.91 | 2021-2024 | Micra |
| Boston Scientific Corporation | $241.31 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor, Watchman |
| Medtronic Vascular, INC. | $190.37 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.66 | 2020-2022 | |
| Abiomed | $144.47 | 2023 | Impella |
| Edwards Lifesciences Corporation | $130.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $119.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.29 | 2021 | |
| Amgen INC. | $99.87 | 2019-2023 | Repatha |
| Kestra Medical Technology Services, INC. | $73.75 | 2025 | Assure Wcd |
| Lundbeck LLC | $58.53 | 2019-2021 | |
| Novo Nordisk INC | $58.05 | 2021-2023 | Wegovy |
| Janssen Pharmaceuticals, INC | $56.69 | 2020-2022 | |
| Pfizer INC. | $46.27 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $44.23 | 2022-2023 | Carto 3 |
| G Medical Diagnostic Services, INC. | $40.29 | 2022-2024 | Cardiac Monitoring Suite |
| Irhythm Technologies, INC. | $38.15 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $36.01 | 2024 | (5091) Amb Mon & Diag Und |
| Biotronik INC. | $35.18 | 2023 | Biomonitor |
| Abbvie INC. | $32.20 | 2022-2023 | Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $29.61 | 2023-2024 | Arexvy |
| Cvrx, INC. | $29.14 | 2024 | Barostim Neo System |
| Daiichi Sankyo INC. | $27.69 | 2025 | Injectafer |
| Agepha Pharma Fz LLC | $23.79 | 2024 | Lodoco |
| Astrazeneca Pharmaceuticals LP | $21.66 | 2020 | |
| Bardy Diagnostics, INC. | $20.00 | 2022 | |
| Merck Sharp & Dohme LLC | $19.85 | 2025 | Capvaxive, Gardasil 9 |
| Akcea Therapeutics, INC. | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Saltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.